Progress of targeted drugs and diagnostic markers for non-small-cell lung cancer in precision medicine
ZHANG Ying
HU Yanping
MA Zhongliang
LI Qian
Abstract：Lung cancer is the most serious malignant tumor in incidence and lethality with short survival time and high recurrence rate. Delightfully, precision medicine has been a promising cure for lung cancer, including agents targeting driver mutations, treatments targeting genes involved in signaling pathway and microRNAs used as potential medicine along with diagnostic marker. We summarized the history and progress of precision medcine in non-small-cell lung cancer.
Keywords：Non-small-celllung cancer ( NSCLC)Precision medicineDriver mutationsmicroRNA
Publication Date：2018-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 182-187 )